|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 27, 2020 11:26AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 26, 2020 05:37AM
|
|
Re: Resverlogix Announces Warrant Repricing and One-Year Extension
|
1
|
Resverlogix Corp.
|
Jun 30, 2023 07:07AM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
1
|
Resverlogix Corp.
|
Nov 25, 2019 06:13PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 06:24PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 06:31PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 06:37PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 06:56PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 07:04PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
1
|
Resverlogix Corp.
|
Nov 25, 2019 07:56PM
|
|
Re: Resverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture Extension
|
2
|
Resverlogix Corp.
|
Aug 01, 2024 10:41AM
|
|
Re: Resverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture Extension
|
2
|
Resverlogix Corp.
|
Aug 01, 2024 11:34AM
|
|
Re: Resverlogix Announces Voting Results from the 2023 Meeting of Shareholders
|
|
Resverlogix Corp.
|
Jun 21, 2023 08:34AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
1
|
Resverlogix Corp.
|
Sep 30, 2019 09:07AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
1
|
Resverlogix Corp.
|
Jul 15, 2019 01:21PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
1
|
Resverlogix Corp.
|
Aug 04, 2020 04:12PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
2
|
Resverlogix Corp.
|
Aug 07, 2020 11:56AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
1
|
Resverlogix Corp.
|
Apr 01, 2020 07:20AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
1
|
Resverlogix Corp.
|
Apr 01, 2020 10:41AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 11:57AM
|
